Why is Jay Bhattacharya running the CDC?

How leadership is changing and what to watch

The director of the National Institutes of Health has been appointed to lead the Centers for Disease Control and Prevention on an acting basis. This temporary arrangement was announced as the administration searches for a permanent CDC director. Having one official run both agencies is unusual and has drawn scrutiny from public-health experts and professional groups.

Concerns and context

• Observers worry the dual role could disrupt continuity at a time when the CDC faces multiple urgent tasks, including vaccine policy, outbreak response, and disease surveillance.
• The move comes amid broader upheaval at the Department of Health and Human Services, where changes in senior staff and vaccine policy have already prompted legal challenges and public debate.
• Experts have flagged that frequent leadership turnover can complicate long-term planning, especially when major advisory committees and programs require sustained engagement.

Things to monitor

• The status and scheduling of vaccine advisory meetings and whether postponed sessions are rescheduled.
• Any changes in CDC guidance on immunization, surveillance, or outbreak response that could affect schools and hospitals.
• Staffing and vacancy trends at the agency that affect operational capacity.

Why it matters

The acting leadership decision will shape how the CDC handles imminent public-health threats and how it maintains relationships with state and local health departments. In the short term, the agency will continue its core outbreak-response duties; longer term, the arrangement could influence public trust and the pace of policy decisions.